Merck Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies
Business Wire India Saturnus Bio is a next-generation precision cardiology company that utilizes targeted gene modulation to address rare…